CHAD Therapeutics revenue down, loss up in 2Q
14th Nov 2006, 20:07 GMT
CHAD Therapeutics Inc. reported a decline in revenue and a larger net loss in its second quarter, the company said Tuesday.
CHAD Therapeutics revenue down, loss up in 2Q related news:
- Repros Therapeutics 3Q Loss Widens — Financial News News from StratCenter.com
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue — Partnerships/ Joint Ventures News from StratCenter.com
- Chelsea Therapeutics posts 3Q loss — Latest news from Charlotte Business Journal
- Quarterly loss, revenue increase for ICOP — Latest news from Kansas City Business Journal
- Loss is flat, revenue jumps for AMC — bizjournals.com Economic View:Bankruptcies headlines
- Genelabs's Q3 loss shrinks as revenue more than doubles — Latest news from Silicon Valley/San Jose Business Journal
- Chad's record diminished by loss — Cincinnati Enquirer - Bengals
- China Medical FYE 2Q Profit Rises — Financial News News from StratCenter.com
- Tacere Therapeutics Appoints VP, R&D — Pharmaceuticals News from StratCenter.com
- Solexa Narrows 3Q Loss — Bio-Technology News from StratCenter.com
Latest news from Latest news from Los Angeles Business from bizjournals:
- Tag-It Pacific earnings, sales up in 3Q
- Starz creates film company
- Spectrum Pharmaceuticals gets $5M milestone payment
- KB Home CEO, 2 others, ousted over options
- First Consulting Group president resigns, senior vice president appointed
- Reliance prices offering of $600M in senior unsecured notes
- Dreamworks registers for $330M follow-on offering